Pharmacogenomic Testing in Practice: How Much Evidence Do We Need?

Genomics|Update|Current

Pharmacogenomic Testing in Practice: How Much Evidence Do We Need?

Evidence required to demonstrate clinical utility of pharmacogenetic testing: The debate continues. 
N K Gillis and F Innocenti. Clinical Pharmacology & Therapeutics (2014); 96 6, 655–657.

Useless until proven effective: The clinical utility of preemptive pharmacogenetic testing. 
A C J W Janssens and P A Deverka  Clinical Pharmacology & Therapeutics (2014); 96 6, 652–654.

Meaningful use of pharmacogenetics. 
M J Ratain and J A Johnson Clinical Pharmacology & Therapeutics (2014); 96 6, 650–652. 

Check out our Pharmacogenomic Testing update page for additional information and links